{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:51:42Z","timestamp":1790355102500,"version":"4.1.0"},"reference-count":40,"publisher":"American Diabetes Association","issue":"8","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100022835","name":"Sociedad Espa\u00f1ola de Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022835","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To assess the effect of a population-wide implementation of intermittently scanned continuous glucose monitoring (isCGM) on hospitalization rates and trends, length of stay, and inpatient health care costs among adults with insulin-treated type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>This population-based, longitudinal, quasi-experimental cohort study included adults with T2D taking multiple daily insulin injections who initiated publicly funded isCGM between April 2022 and December 2023. Hospitalizations for acute diabetes-related complications (diabetic ketoacidosis, hyperglycemic hyperosmolar state, simple hyperglycemia, and hypoglycemia) and cardiovascular complications (myocardial infarction, stroke, and major lower-extremity amputation) were identified using ICD-10 codes. Incidence rates and rate ratios (RRs) were estimated using Poisson models. Interrupted time series analyses were used to estimate counterfactual trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Among 15,413 participants, the mean follow-up was 22.5 \u00b1 4.6 months before and 19.1 \u00b1 4.4 months after isCGM initiation. Mean HbA1c decreased from 8.09 to 7.65% (mean difference \u22120.44 [95% CI \u22120.47 to \u22120.42]). Diabetes-related hospitalization rates decreased from 74.6 to 27.5 per 10,000 person-years (RR 0.37 [95% CI 0.28\u20130.49]). Cardiovascular hospitalization rates remained stable (228.8 vs. 215.8 per 10,000 person-years; RR 0.94 [0.84\u20131.06]). Interrupted time series analyses showed a change in cardiovascular admission rates after isCGM initiation relative to the preintervention trend. Median length of stay decreased from 4 (interquartile range 5) to 3 (4) days. Total inpatient costs decreased by $3,806,776.90 (\u2013$955,186.70 per 10,000 person-years).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>In this real-world study, implementation of isCGM among insulin-treated adults with T2D was associated with substantial reductions in acute diabetes-related hospitalizations, shorter hospital stays, lower health care costs, and changes in cardiovascular hospitalization trends.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc26-0547","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:46:22Z","timestamp":1781621182000},"page":"1442-1450","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":1,"title":["Implementation of Intermittently Scanned Continuous Glucose Monitoring and Changes in Hospitalizations and Health Care Costs in Insulin-Treated Type 2 Diabetes"],"prefix":"10.2337","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0951-5428","authenticated-orcid":false,"given":"Pablo","family":"Rodr\u00edguez de Vera G\u00f3mez","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Nutrition, Virgen Macarena University Hospital 1 , Seville, Spain"},{"name":"Institute of Biomedicine of Seville (IBis), University Hospital Macarena\/CSIC\/University of Seville 2 , Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mayoral","sequence":"additional","affiliation":[{"name":"Andalusian Diabetes Plan, Ministry of Health and Consumer Affairs, Regional Government of Andalusia 3 , Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Rodr\u00edguez Jim\u00e9nez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Virgen Macarena University Hospital 1 , Seville, Spain"},{"name":"Institute of Biomedicine of Seville (IBis), University Hospital Macarena\/CSIC\/University of Seville 2 , Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0106-0091","authenticated-orcid":false,"given":"Fernando","family":"Gomez-Peralta","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Segovia General Hospital 4 , Segovia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3252-5026","authenticated-orcid":false,"given":"Guillermo E.","family":"Umpierrez","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, Emory University School of Medicine 5 , Atlanta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9740-122X","authenticated-orcid":false,"given":"Mar\u00eda Asunci\u00f3n","family":"Mart\u00ednez-Brocca","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nutrition, Virgen Macarena University Hospital 1 , Seville, Spain"},{"name":"Institute of Biomedicine of Seville (IBis), University Hospital Macarena\/CSIC\/University of Seville 2 , Seville, Spain"},{"name":"Andalusian Diabetes Plan, Ministry of Health and Consumer Affairs, Regional Government of Andalusia 3 , Seville, Spain"},{"name":"Department of Medicine, University of Seville 6 , Seville, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"2026072014525040500_B1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12933-024-02358-0","article-title":"Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study","volume":"23","author":"Gonzalez-Manzanares","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"2026072014525040500_B2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"2026072014525040500_B3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","article-title":"Interpreting global trends in type 2 diabetes complications and mortality","volume":"65","author":"Ali","year":"2022","journal-title":"Diabetologia"},{"key":"2026072014525040500_B4","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1080\/03007995.2022.2125259","article-title":"Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease","volume":"38","author":"King","year":"2022","journal-title":"Curr Med Res Opin"},{"key":"2026072014525040500_B5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41574-024-00973-1","article-title":"Continuous glucose monitoring for the routine care of type 2 diabetes mellitus","volume":"20","author":"Ajjan","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"2026072014525040500_B6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s13300-025-01830-8","article-title":"The expanding role of continuous glucose monitoring in the management and prevention of type 2 diabetes","volume":"17","author":"Son","year":"2026","journal-title":"Diabetes Ther"},{"key":"2026072014525040500_B7","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.2337\/dc20-1690","article-title":"Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF study","volume":"44","author":"Roussel","year":"2021","journal-title":"Diabetes Care"},{"key":"2026072014525040500_B8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/dia.2022.0085","article-title":"Reduced rate of acute diabetes events with flash glucose monitoring is sustained for 2 years after initiation: extended outcomes from the RELIEF study","volume":"24","author":"Riveline","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026072014525040500_B9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00125-021-05437-z","article-title":"Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls","volume":"64","author":"Nathanson","year":"2021","journal-title":"Diabetologia"},{"key":"2026072014525040500_B10","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.2337\/dc24-0690","article-title":"Initiation of intermittently scanned continuous glucose monitoring is associated with reduced hospitalization for acute diabetes events and cardiovascular complications in adults with type 1 diabetes","volume":"47","author":"Eeg-Olofsson","year":"2024","journal-title":"Diabetes Care"},{"key":"2026072014525040500_B11","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S2213-8587(23)00225-5","article-title":"Current insights and emerging trends in early-onset type 2 diabetes","volume":"11","author":"Misra","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072014525040500_B12","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s13300-019-0656-9","article-title":"Short-term versus long-term adverse cardiovascular outcomes post percutaneous coronary intervention in patients with insulin-treated type 2 diabetes mellitus: a simple meta-analysis","volume":"10","author":"Lu","year":"2019","journal-title":"Diabetes Ther"},{"key":"2026072014525040500_B13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.2337\/dc25-0014","article-title":"The Diabetes Prevention Program and its outcomes study: NIDDK\u2019s journey into the prevention of type 2 diabetes and its public health impact","volume":"48","author":"Crandall","year":"2025","journal-title":"Diabetes Care"},{"key":"2026072014525040500_B14","unstructured":"Consejer\u00eda de Salud\n          . Plan integral de diabetes de Andaluc\u00eda (actualizaci\u00f3n 2016). Accessed 8 June 2026. Available from https:\/\/www.juntadeandalucia.es\/export\/drupaljda\/salud_5af065335c108_pidma3.pdf"},{"key":"2026072014525040500_B15","unstructured":"Junta de Andaluc\u00eda\n          . Bolet\u00edn oficial de la Junta de Andaluc\u00eda \u2013 hist\u00f3rico del BOJA, 2022. Accessed 8 June 2026. Available from https:\/\/www.juntadeandalucia.es\/boja\/2022\/75\/62"},{"key":"2026072014525040500_B16","first-page":"501661","article-title":"Outcomes of a population-based flash glucose monitoring program in adults with type 2 diabetes mellitus on intensive insulin therapy in Andalusia","volume":"73","author":"Peinado Ru\u00edz","year":"2026","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"2026072014525040500_B17","unstructured":"Servicio Andaluz de Salud\n          . Precios p\u00fablicos. Accessed 31 January 2026. Available from https:\/\/www.sspa.juntadeandalucia.es\/servicioandaluzdesalud\/profesionales\/relacion-con-la-ciudadania\/precios-publicos"},{"key":"2026072014525040500_B18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13098-021-00654-3","article-title":"A review of flash glucose monitoring in type 2 diabetes","volume":"13","author":"Krakauer","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"2026072014525040500_B19","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/dia.2022.0063","article-title":"Dynamics of hemoglobin A1c, body mass index, and rates of severe hypoglycemia in 4434 adults with type 1 or type 2 diabetes after initiation of continuous glucose monitoring","volume":"24","author":"Lanzinger","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"2026072014525040500_B20","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s12933-025-02959-3","article-title":"Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy","volume":"24","author":"Standl","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"2026072014525040500_B21","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1089\/dia.2021.0007","article-title":"Type 2 diabetes and the use of real-time continuous glucose monitoring","volume":"23","author":"Jackson","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"2026072014525040500_B22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026072014525040500_B23","doi-asserted-by":"crossref","first-page":"e002032","DOI":"10.1136\/bmjdrc-2020-002032","article-title":"Glycemic variability and cardiovascular disease in patients with type 2 diabetes","volume":"9","author":"Martinez","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2026072014525040500_B24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1089\/dia.2022.0447","article-title":"Increased derived time in range is associated with reduced risk of major adverse cardiovascular events, severe hypoglycemia, and microvascular events in type 2 diabetes: a post hoc analysis of DEVOTE","volume":"25","author":"Bergenstal","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026072014525040500_B25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S2213-8587(24)00242-0","article-title":"Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)","volume":"12","author":"Lin","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026072014525040500_B26","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.3390\/ijms24119357","article-title":"Effects of hypoglycemia on cardiovascular function in patients with diabetes","volume":"24","author":"Christou","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2026072014525040500_B27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.clnu.2024.02.014","article-title":"Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: a systematic review and meta-analysis","volume":"43","author":"Hjort","year":"2024","journal-title":"Clin Nutr"},{"key":"2026072014525040500_B28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/1932296818790994","article-title":"Behavior modification in prediabetes and diabetes: potential use of real-time continuous glucose monitoring","volume":"13","author":"Ehrhardt","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"2026072014525040500_B29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jcjd.2023.04.001","article-title":"How continuous glucose monitoring can motivate self-management: can motivation follow behaviour?","volume":"47","author":"Vallis","year":"2023","journal-title":"Can J Diabetes"},{"key":"2026072014525040500_B30","doi-asserted-by":"crossref","first-page":"112907","DOI":"10.1016\/j.diabres.2025.112907","article-title":"Effects of continuous glucose monitoring on dietary behavior and physical activity: a systematic review and meta-analysis","volume":"229","author":"Zhang","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"2026072014525040500_B31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/clinem\/dgac596","article-title":"Management of individuals with diabetes at high risk for hypoglycemia: an endocrine society clinical practice guideline [published correction appears in J Clin Endocrinol Metab 2023;108:e44]","volume":"108","author":"McCall","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026072014525040500_B32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40266-021-00910-1","article-title":"Management of hyperglycemia in older adults with type 2 diabetes","volume":"39","author":"Gandhi","year":"2022","journal-title":"Drugs Aging"},{"key":"2026072014525040500_B33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12933-021-01273-y","article-title":"Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data","volume":"20","author":"Lopez-de-Andres","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2026072014525040500_B34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/19322968241234651","article-title":"Continuous glucose monitoring in older adults: what we know and what we have yet to learn","volume":"18","author":"Price","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"2026072014525040500_B35","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2337\/dc21-2268","article-title":"Trends in the incidence of hospitalization for major diabetes-related complications in people with type 1 and type 2 diabetes in Australia, 2010-2019","volume":"45","author":"Morton","year":"2022","journal-title":"Diabetes Care"},{"key":"2026072014525040500_B36","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1089\/dia.2023.0149","article-title":"Prevalence, cost, and burden of diabetic ketoacidosis","volume":"25","author":"Virdi","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2026072014525040500_B37","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2147\/CEOR.S483459","article-title":"Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated type 2 diabetes in Spain","volume":"16","author":"Merino-Torres","year":"2024","journal-title":"Clinicoecon Outcomes Res"},{"key":"2026072014525040500_B38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/dme.12647","article-title":"The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)","volume":"32","author":"Alva","year":"2015","journal-title":"Diabet Med"},{"key":"2026072014525040500_B39","doi-asserted-by":"crossref","first-page":"e2528933","DOI":"10.1001\/jamanetworkopen.2025.28933","article-title":"Global inequities in diabetes technology and insulin access and glycemic outcomes","volume":"8","author":"Santova","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026072014525040500_B40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.15470","article-title":"Technology and health inequities in diabetes care: how do we widen access to underserved populations and utilize technology to improve outcomes for all?","volume":"26","author":"Ebekozien","year":"2024","journal-title":"Diabetes Obes Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/8\/1442\/887405\/dc260547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/8\/1442\/887405\/dc260547.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:53:05Z","timestamp":1784573585000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/8\/1442\/172100\/Implementation-of-Intermittently-Scanned"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,6,16]]},"published-print":{"date-parts":[[2026,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-0547","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]}}}